Seppo W. Langer

Seppo W. Langer

Clinical Associate Professor

Member of:

  • Clinical Oncology


  1. 2012
  2. Published

    Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal poorly differentiated neuroendocrine carcinoma: The NORDIC NEC study

    Sorbye, H., Welin, S., Langer, Seppo W., Vestermark, L. W., Holt, N., Osterlund, P. J., Dueland, S., Hofsli, E., Guren, M. G., Ohrling, K., Birkemeyer, E., Thiis-Evensen, E., Biagini, M., Gronbaek, H., Soveri, L., Olsen, I. H., Federspiel, B., Assmus, J., Janson, E. T. & Knigge, Ulrich, 20 May 2012, In: Journal of Clinical Oncology. 30, 15, 1 p.

    Research output: Contribution to journalConference articleResearchpeer-review

  3. Published

    A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer

    Grønberg, B. H., Ciuleanu, T., Fløtten, Ø., Knuuttila, A., Abel, E., Langer, Seppo W., Krejcy, K., Liepa, A. M., Munoz, M., Hahka-Kemppinen, M. & Sundstrøm, S., Oct 2012, In: Lung Cancer. 78, 1, p. 63-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 33841728